Spanish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
anemia/inflamación
El enlace se guarda en el portapapeles.
Página 1 desde 73 resultados
Methods of treating anemia using anti-IL-6 antibodies
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
The sequence listing in the file named "67858o707001v3.txt" having a size of 342,545 bytes that was created Jun. 13, 2012 is hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is an extension of Applicants' prior invention disclosed
Mono (iron hydroxypyrone) and combination (iron hydroxypyrone and GI inflammation inhibiting agents) compositions for anaemia or H. pylori infections
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
This invention relates to therapeutic compositions which comprise iron ions and to their medical applications.
An adequate supply of iron to the body is an essential requirement for tissue growth and the maintenance of good health in both man and animals. Moreover, in certain pathological conditions
Methods for treating pain caused by inflammation induced mechanical and/or thermal hypersensitivity
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND
It has been reported that pain is most often the principal reason for pediatric patients to seek medical treatment. Pain management in children is a significant clinical problem. Post-operative pain or surgical pain is one type of pain that is sometimes undertreated to avoid potentially
Methods of treating destructive inflammation of the mucous membranes with lactoferrin
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a U.S. national stage application filed under 35 U.S.C. .sctn.371 of International Patent Application PCT/EP2006/003106, accorded an international filing date of Apr. 5, 2006, which claims the benefit of Italian Patent Application No.
Substituted quinolines and their uses in treatment of inflammatory and related conditions
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
The present invention relates generally to phosphatidylinositol 3-kinase (PI3K) enzymes, and more particularly to selective inhibitors of PI3K activity and to methods, of using such materials.
BACKGROUND OF THE INVENTION
Cell signaling via 3'-phosphorylated phosphoinositides has been implicated in a
Sulfonaminoquinoline hepcidin antagonists
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
INTRODUCTION
The invention relates to novel hepcidin antagonists of the general formula (I), pharmaceutical compositions comprising these and their use for treatment of iron metabolism disorders, in particular of anaemias in connection with chronic inflammatory diseases (anaemia of chronic disease
Erythropoeitin production by electrical stimulation
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
TECHNICAL FIELD
This application relates generally to implantable stimulation devices and, more specifically, but not exclusively to providing electrical stimulation to increase the production of erythropoietin.
BACKGROUND
Anemia is defined by the World Health Organization's as hemoglobin
Erythropoeitin production by electrical stimulation
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
TECHNICAL FIELD
This application relates generally to implantable stimulation devices and, more specifically, but not exclusively to providing electrical stimulation to increase the production of erythropoietin.
BACKGROUND
Anemia is defined by the World Health Organization's as hemoglobin
Human protein kinases hYAK3-2
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION
This invention relates to newly identified polynucleotides, polypeptides encoded by them and to the use of such polynucleotides and polypeptides, and to their production. More particularly, the polynucleotides and polypeptides of the present invention relate to a serine/threonine
Thiazolidinediones of omega-3 polyunsaturated acids as new insulin sensitizers for treating type2 diabetes
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The present invention relates to novel thiazolidinedione derivatives of omega-3 fatty acids used as insulin sensitizers for treating Type2 diabetes, obesity, hypertriglyceridemia, cardiovascular diseases, metabolic diseases, inflammation, cancer, renal anemia, Alzheimer's
Interleukin-6 to stimulate erythropoietin production
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the use of interleukin-6 to stimulate the production of endogenous erythropoietin in cells in vitro and in vivo. The invention further includes methods of treatment wherein interleukin-6 is administered to humans
Methods and compositions for regulating iron homeostasis by modulation of BMP-6
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
TECHNICAL FIELD OF THE INVENTION
The present invention relates generally to therapy, prevention and amelioration of iron homeostasis disorders. The invention is more specifically related to methods of using BMP-6 and BMP-6 protein-specific reagents, such as antibodies for altering serum iron, serum
Compositions and methods for silencing SMAD4
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
STATEMENT REGARDING SEQUENCE LISTING
The Sequence Listing associated with this application is provided in text format in lieu of a paper copy, and is hereby incorporated by reference into the specification. The name of the text file containing the Sequence Listing is
Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The present invention is directed to carbonyl compounds as inhibitors of histone deacetylase (HDAC). These compounds are useful in treatments of disease states, including, but not limited to, certain cancers (such as colon cancer, breast cancer, ovarian cancer, lung cancer,
Crystal forms of immunomodulatory drug pomalidomide and co-crystal with gentisic acid
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a 371 of PCT/EP2016/078726, filed Nov. 24, 2016, which claims the benefit of Italian Application No. UB2016A009994, filed Jan. 14, 2016.
FIELD OF THE INVENTION
The present invention relates to new solid forms of Pomalidomide, in particular
La base de datos de hierbas medicinales más completa respaldada por la ciencia
- Funciona en 55 idiomas
- Curas a base de hierbas respaldadas por la ciencia
- Reconocimiento de hierbas por imagen
- Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
- Leer publicaciones científicas relacionadas con su búsqueda
- Buscar hierbas medicinales por sus efectos.
- Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.
Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.
